Over A week ago I speculated ( per Viking ) that something was up, that ” a partnership or buyout was was very, very close ” because the trading was way to controlled…daveraj noticed it also..after a few days of nada I ” threw in the towel” and bought SMCI with the funds…That was a fantastic trade – from $ 39 – as posted… Well, those funds and the windfall from MLGO today, are Back in Viking..
The next time a hedge fund or Bloomberg or CNBC or whoever says small caps and mid caps will benefit from a broader participation. A thinning out of mag7 concentration…remember them? Look at small and mid caps today. Where are they? That is like saying Bezos’s yacht is going to fit in your local pond. IWM
baz22
February 21, 2025 5:43 pm
#44958
My premise is simple…when economic pressure’s increase, hence stress, etc..,so will incidence of cancers, heart attacks, etc… biotech is at a 4 year bottom…could go lower, but most people want to live… I’ve always said, ‘ when faced with death, do you want to pay for a new I phone, EV, etc..or medical treatment…? Obesity is also cardiovascular and liver issues
Personally, I think the obesity epidemic is just starting… Just check any grocery store, and where the cheapest prices are .. People are going broke paying rent, mortgage and food…
My logical guess is Bridgewater has sold their purchase of TSLA last quarter, and they are likely enjoying this ride down too! I find it very criminal how financial media was touting last week all over the wires on up days for TSLA that Bridgewater bought last qtr in size. But failed to connect the dots when they bought or if they has doubled their money already and were selling to us with the help of headlines.
$UNH seemed to be in a massive bubble even without the DOJ inquiry; trading 590 a share late November; P/E approaching 30; Book value 109; dividend 1.4% who tf buys this up near 600 a share.
A big thank you to NYUGrad for his invaluable support in proofreading the weekly Global Market Navigator Report andcreating the DeepMind audio discussions. Today, he’s helping me gather your feedback to optimize and improve it.
Please take a moment to complete the survey linked above. That would be very helpful.
In my over 40 years as a professional and nearly 20 years as a private investor, I’ve never seen challenges in financial markets as significant as they are today. Amid the overwhelming flood of daily commentary, only a handful, in my view, are truly worth the time and cost to consider. That’s why I’ve been consistently impressed by the stream of excellent ideas shared daily at NotYourAdvisor.com, courtesy of NYUGrad.
I’m thrilled to see him receiving well-deserved 5-star reviews at Substack. I wholeheartedly recommend his service to serious investors and traders, and I’m grateful that he’s generously offered us a huge discount on the annual billing option.
WMT…Walmart has a PARABOLIC problem. Most recent stories I am hearing is that wealthy people are now shopping at Walmart. Yeah OK LOL, seems to me stories are being written as those holding the strings liquidate to the sheep. Needs Some volume so the Big boys can move shares more easily.
Iova..from Q3 in November 2024… “A cash position of $403.8m was reported. Operationally speaking, management stated that:
Onboarding is complete at 56 U.S. Authorised Treatment Centers (“ATCs”) across 29 states and more than 90% of addressable patients are now located within 200 miles of an ATC. Approximately 70 ATCs remain on track to be onboarded by the end of 2024.
Management also confirmed that reimbursement “remains successful”, with an average financial clearance time of ~3 weeks, that 75% of enrolled Amtagvi patients were covered by private payors, and that “payers or plans covering more than 250 million lives have added Amtagvi to policies since its launch.”
A marketing authorization application (“MAA”) has also been filed to the European Medicines Agency (“EMA”) for approval of Amtagvi there, with a decision expected in the first half of next year.
On the Q3 earnings call with analysts, Iovance’s CEO Fred Vogt told analysts:
We anticipate significant additional revenue growth in 2026 and beyond. In the currently approved advanced melanoma indication alone, Amtagvi and Proleukin represent more than a $1 billion peak opportunity in the U.S. market. Globally, Amtagvi represents a multibillion dollar opportunity to address more than 20,000 previously treated advanced melanoma patients annually in the U.S. and in our initial ex- U.S. markets.”
Exploring MLGO news.. could be very … got In very early ah QPU is global F tariffs ” “For cloud players, given the predilection of GOP policies to be more permissive around M&A, and perhaps less immediate regulation around AI, I would expect more leeway for cloud players to grow in unique areas acquisitively (likely in the AI/GenAI space),” AvidThink Founder Roy Chua”
Upper middle class getting squeezed and migrating from premium retail and grocers down to Walmart. I can empathize. If you breath in a Whole Foods you are charged $50 USD https://youtu.be/WgJPDln3vUw
You would think XLY and XRT would be leading south today with Walmart. But it is Financials down the most. XLF KBE. Always have eye on the forest before the trees
After I published the following commentary today, maybe common sense is returning to market prices.
Americans are soon to discover the other side of the Trump coin. A surge in inflation as soon as his tariffs are applied, work stoppages because of supply-chain problems, lawsuits galore, and national strikes within the country. There is no way the stock market can withstand such an assault — unless Trump takes power away from the capitalist system and he personally sets interest rates and commodity prices, blocks worker strikes, and uses the military to force other countries to send economically required materials and energy to his country.
I’m hoping Mr. Market delivers the message to the oligarchs who support Trump, and they, in turn, tell him to start acting like the fit and proper President the USA needs.
Brought on December 17th 50 contract EDIT strike $5 expire january 16 2026 paid $0.26 premium almost double now to 0.56, I have many option contract that expire January 2026, hope– some will do very good,
PDAC 2025 World’s Biggest Mining Convention March 2-5
I plan to attend on March 3rd and the afternoon of the 4th. Listening to the stories, seeing the hype, and meeting old friends and acquaintances is always interesting.
I’ll be in the media room again this year for those who wish to meet.
To acknowledge the highest-risk, highest-reward part of the business, I hope to meet 15 junior prospectors there as part of the 25 I will be writing up in this weekend’s Navigator 7 Report:
Founders Metals–my only observation is that it’s getting to that point on the Lassonde curve where speculators start to think about taking profits. Maybe not yet but it’s getting there.
Agreed. I certainly would not buy any of them at this point. But these companies have been succeeding for reasons of having skilled promoters and managers, access to risk capital, and geologically interesting properties.
Within a year, I can see some of these stocks trading at small fractions if the current market. Having these companies on a watchlist is a preparation for future decisions that many investors and traders might choose to do.
More rumors, on Wall Street ( Betaville ‘ uncooked ‘ alert ), of Lilly ( and I’m betting Pfizer ) preparing bids for VKTX
Of course I’m back in
was early am
Over A week ago I speculated ( per Viking ) that something was up, that ” a partnership or buyout was was very, very close ” because the trading was way to controlled…daveraj noticed it also..after a few days of nada I ” threw in the towel” and bought SMCI with the funds…That was a fantastic trade – from $ 39 – as posted… Well, those funds and the windfall from MLGO today, are Back in Viking..
The next time a hedge fund or Bloomberg or CNBC or whoever says small caps and mid caps will benefit from a broader participation. A thinning out of mag7 concentration…remember them? Look at small and mid caps today. Where are they?
That is like saying Bezos’s yacht is going to fit in your local pond.
IWM
My premise is simple…when economic pressure’s increase, hence stress, etc..,so will incidence of cancers, heart attacks, etc… biotech is at a 4 year bottom…could go lower, but most people want to live… I’ve always said, ‘ when faced with death, do you want to pay for a new I phone, EV, etc..or medical treatment…?
Obesity is also cardiovascular and liver issues
Personally, I think the obesity epidemic is just starting… Just check any grocery store, and where the cheapest prices are .. People are going broke paying rent, mortgage and food…
2 days ago…I could have helped side step some of yesterday and all of today.
Topics covered on today’s podcast
My logical guess is Bridgewater has sold their purchase of TSLA last quarter, and they are likely enjoying this ride down too! I find it very criminal how financial media was touting last week all over the wires on up days for TSLA that Bridgewater bought last qtr in size. But failed to connect the dots when they bought or if they has doubled their money already and were selling to us with the help of headlines.
$UNH seemed to be in a massive bubble even without the DOJ inquiry; trading 590 a share late November; P/E approaching 30; Book value 109; dividend 1.4% who tf buys this up near 600 a share.
Bill Cara Global Market Navigator Report Survey
A big thank you to NYUGrad for his invaluable support in proofreading the weekly Global Market Navigator Report and creating the DeepMind audio discussions. Today, he’s helping me gather your feedback to optimize and improve it.
https://docs.google.com/forms/d/e/1FAIpQLSeKEG_6JkESqlsFfqdT_eLqexyz1uMP4CbvBc0E5f87LlERtA/viewform
Please take a moment to complete the survey linked above. That would be very helpful.
In my over 40 years as a professional and nearly 20 years as a private investor, I’ve never seen challenges in financial markets as significant as they are today. Amid the overwhelming flood of daily commentary, only a handful, in my view, are truly worth the time and cost to consider. That’s why I’ve been consistently impressed by the stream of excellent ideas shared daily at NotYourAdvisor.com, courtesy of NYUGrad.
I’m thrilled to see him receiving well-deserved 5-star reviews at Substack. I wholeheartedly recommend his service to serious investors and traders, and I’m grateful that he’s generously offered us a huge discount on the annual billing option.
https://www.notyouradvisor.com/billcara
WMT…Walmart has a PARABOLIC problem. Most recent stories I am hearing is that wealthy people are now shopping at Walmart. Yeah OK LOL, seems to me stories are being written as those holding the strings liquidate to the sheep. Needs Some volume so the Big boys can move shares more easily.
Check out BAH… Trading 34x cheaper than Pltr
https://moneymorning.com/2025/02/20/best-ai-stock-in-2025-70-upside-and-trades-34x-cheaper-than-pltr/
Soon !
Navel gazing. My paid alert got folks in, in the $40-50 range. I would be happy for someone to take my shares now. Stops in place.
Got in MLGO at $ 2.26 after-hours yesterday…sold at $ 10.06
Close enough to parab for me..!!
Iova..from Q3 in November 2024… “A cash position of $403.8m was reported. Operationally speaking, management stated that:
Onboarding is complete at 56 U.S. Authorised Treatment Centers (“ATCs”) across 29 states and more than 90% of addressable patients are now located within 200 miles of an ATC. Approximately 70 ATCs remain on track to be onboarded by the end of 2024.
Management also confirmed that reimbursement “remains successful”, with an average financial clearance time of ~3 weeks, that 75% of enrolled Amtagvi patients were covered by private payors, and that “payers or plans covering more than 250 million lives have added Amtagvi to policies since its launch.”
A marketing authorization application (“MAA”) has also been filed to the European Medicines Agency (“EMA”) for approval of Amtagvi there, with a decision expected in the first half of next year.
On the Q3 earnings call with analysts, Iovance’s CEO Fred Vogt told analysts:
We anticipate significant additional revenue growth in 2026 and beyond. In the currently approved advanced melanoma indication alone, Amtagvi and Proleukin represent more than a $1 billion peak opportunity in the U.S. market. Globally, Amtagvi represents a multibillion dollar opportunity to address more than 20,000 previously treated advanced melanoma patients annually in the U.S. and in our initial ex- U.S. markets.”
Now we know why banks sold off.(Sarcasm) ‘When Wall St and Corp CEOs shook in fear.’
Epstein and Diddy list leak imminent
It’s gonna be lit at Lake Tahoe this summer. You are not invited …
Meta approves plan for bigger executive bonuses following 5% layoffs
https://www.cnbc.com/2025/02/20/meta-approves-plan-for-bigger-executives-bonuses-following-5percent-layoffs.html
G
Exploring MLGO news.. could be very … got In very early ah
QPU is global
F tariffs
” “For cloud players, given the predilection of GOP policies to be more permissive around M&A, and perhaps less immediate regulation around AI, I would expect more leeway for cloud players to grow in unique areas acquisitively (likely in the AI/GenAI space),” AvidThink Founder Roy Chua”
Upper middle class getting squeezed and migrating from premium retail and grocers down to Walmart. I can empathize. If you breath in a Whole Foods you are charged $50 USD
https://youtu.be/WgJPDln3vUw
Actually, you are only billed when you exhale. CO2 and Climate Change. You can purchase carbon credits on your way out.
You would think XLY and XRT would be leading south today with Walmart. But it is Financials down the most. XLF KBE. Always have eye on the forest before the trees
The US stock market is flashing an Alert
After I published the following commentary today, maybe common sense is returning to market prices.
I’m hoping Mr. Market delivers the message to the oligarchs who support Trump, and they, in turn, tell him to start acting like the fit and proper President the USA needs.
https://youtu.be/ZEcqHA7dbwM?si=8r01WzNom98Wh-mI
Went and sold…wait till earnings
Buying Iovance right on top of recently CFO options
Sell-off in Walmart (WMT -6.3%) on large volume at the open.
There are people still stuck in these ev car stocks.
I find it simply easier just trading one stock
EDIT up 80% on huge volume.
Brought on December 17th 50 contract EDIT strike $5 expire january 16 2026 paid $0.26
premium almost double now to 0.56, I have many option contract that expire January 2026, hope– some will do very good,
Wall St in a commerical.
https://youtu.be/udafZUQsgsk
PDAC 2025 World’s Biggest Mining Convention March 2-5
I plan to attend on March 3rd and the afternoon of the 4th. Listening to the stories, seeing the hype, and meeting old friends and acquaintances is always interesting.
I’ll be in the media room again this year for those who wish to meet.
To acknowledge the highest-risk, highest-reward part of the business, I hope to meet 15 junior prospectors there as part of the 25 I will be writing up in this weekend’s Navigator 7 Report:
These are not late-stage developers or producers that I’ll also check out at PDAC this year, maybe one of my last.
Founders Metals–my only observation is that it’s getting to that point on the Lassonde curve where speculators start to think about taking profits. Maybe not yet but it’s getting there.
Agreed. I certainly would not buy any of them at this point. But these companies have been succeeding for reasons of having skilled promoters and managers, access to risk capital, and geologically interesting properties.
Within a year, I can see some of these stocks trading at small fractions if the current market. Having these companies on a watchlist is a preparation for future decisions that many investors and traders might choose to do.
“An inch of time is worth an inch of gold, but an inch of gold cannot buy an inch of time.”
-Chinese Proverb
SPX stocks, 12 positions, overall + 0.72%; losers: $HP $DOW $EQNR; winners: $VZ $HAL $MRK $COP; time elapsed mostly mid-Jan and Feb. Dividend yld about 5.4% or so.
Still early.
Kind of figured Devon would finish writing that W, didn’t think the last stroke would be a straight line though.
Editas showing some signs of life
Up 36% just today. What is going on? I see no news.
It’s now up 67%. Dunno, short squeeze, maybe Vertex making an offer…? We’ll see..
https://www.forbes.com/sites/nathanvardi/2023/01/13/for-blood-and-money-book-excerpt-wayne-rothbaum-pharmacyclics-robert-duggan/……these two men are very relevant today
I do Respectfully disagree with NYU on how to succeed in biotech… Biotech, more than Any sector, is about timing and huge research…it’s also about market cycles… currently biotech is on the bottom…but, that will change…
## … I will Never write on biotech again if Iovance Therapeutics is not $ 30 a share in one year from now
wont let me read the article unless i disable my ad blocker which i will not do